EP0746365A4
(en)
*
|
1993-09-14 |
1997-05-21 |
North Shore Lab Pty Ltd |
INJECTION DEVICE
|
CA2551185C
(en)
*
|
1994-03-28 |
2007-10-30 |
Sdgi Holdings, Inc. |
Apparatus and method for anterior spinal stabilization
|
SE9403433D0
(sv)
|
1994-10-10 |
1994-10-10 |
Pharmacia Ab |
Injection device
|
SE9502285D0
(sv)
*
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Improvements related to injections
|
US6058321A
(en)
*
|
1995-09-07 |
2000-05-02 |
Swayze; Claude R. |
Instrument for continuously monitoring fetal heart rate and intermittently monitoring fetal blood pH and method of use
|
EP0828527B1
(de)
*
|
1996-04-02 |
2002-07-31 |
Disetronic Licensing AG |
Injektionsgerät
|
ES2183939T3
(es)
|
1996-04-02 |
2003-04-01 |
Disetronic Licensing Ag |
Aparato de inyeccion.
|
WO1998001171A1
(de)
|
1996-07-05 |
1998-01-15 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
ATE307628T1
(de)
*
|
1996-07-05 |
2005-11-15 |
Tecpharma Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
DE19717107B4
(de)
|
1997-04-23 |
2005-06-23 |
Disetronic Licensing Ag |
System aus Behältnis und Antriebsvorrichtung für einen Kolben, der in dem ein Medikamentfluid enthaltenden Behältnis gehalten ist
|
CN1510936B
(zh)
|
1997-04-24 |
2010-05-26 |
株式会社Ntt都科摩 |
移动通信系统中的通信控制方法
|
DE19740187C1
(de)
*
|
1997-09-12 |
1999-04-15 |
Disetronic Licensing Ag |
Vorrichtung zur dosierten Ausschüttung eines injizierbaren Produkts
|
DE59711650D1
(de)
|
1997-11-17 |
2004-06-24 |
Tecpharma Licensing Ag |
Nadelpenetrationsvorrichtung
|
US6203529B1
(en)
|
1997-11-19 |
2001-03-20 |
B D Medico |
Needle arrangement
|
US6482176B1
(en)
|
1997-11-27 |
2002-11-19 |
Disetronic Licensing Ag |
Method and device for controlling the introduction depth of an injection needle
|
DE19755125B4
(de)
*
|
1997-12-11 |
2006-04-20 |
Tecpharma Licensing Ag |
Nadelschutzvorrichtung für Injektionsgeräte
|
DE69918266T2
(de)
|
1998-01-12 |
2005-08-04 |
Alsensa A.p.S. |
Injektionseinheit
|
US6949111B2
(en)
|
1998-02-13 |
2005-09-27 |
Steven Schraga |
Lancet device
|
US5997509A
(en)
*
|
1998-03-06 |
1999-12-07 |
Cornell Research Foundation, Inc. |
Minimally invasive gene therapy delivery device and method
|
CA2229522A1
(en)
|
1998-04-15 |
1999-10-15 |
Thomas Randall Inkpen |
Needle aid
|
DE19821933C1
(de)
|
1998-05-15 |
1999-11-11 |
Disetronic Licensing Ag |
Vorrichtung zur Verabreichung eines injizierbaren Produkts
|
DE19822031C2
(de)
|
1998-05-15 |
2000-03-23 |
Disetronic Licensing Ag |
Autoinjektionsgerät
|
US6290679B1
(en)
|
1999-05-14 |
2001-09-18 |
Disetronic Licensing Ag |
Device for metered administration of an injectable product
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
DE19925904C1
(de)
|
1999-06-07 |
2001-02-01 |
Disetronic Licensing Ag |
Vorrichtung zur subkutanen Verabreichung eines injizierbaren Produkts
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US7241275B2
(en)
*
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US6776776B2
(en)
*
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US20050070945A1
(en)
*
|
1999-11-02 |
2005-03-31 |
Steven Schraga |
Single use lancet assembly
|
US8814896B2
(en)
|
1999-11-02 |
2014-08-26 |
Stat Medical Devices, Inc. |
Single use lancet assembly
|
US6322575B1
(en)
|
2000-01-05 |
2001-11-27 |
Steven Schraga |
Lancet depth adjustment assembly
|
DE20006251U1
(de)
*
|
2000-04-05 |
2001-08-16 |
B D Medico Gmbh, Mies |
Nadelschutzanordnung
|
US6508802B1
(en)
|
2000-05-23 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
|
US6547764B2
(en)
*
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
US6986760B2
(en)
*
|
2000-08-02 |
2006-01-17 |
Becton, Dickinson And Company |
Pen needle and safety shield system
|
ES2605353T3
(es)
|
2000-08-02 |
2017-03-14 |
Becton, Dickinson And Company |
Sistema de aguja de pluma y pantalla protectora de seguridad
|
DE10044383C2
(de)
*
|
2000-09-08 |
2003-02-06 |
Disetronic Licensing Ag |
Nadelschutzvorrichtung
|
US6958072B2
(en)
*
|
2000-11-10 |
2005-10-25 |
Steven Schraga |
Single use lancet device
|
DE60239594D1
(de)
|
2001-02-23 |
2011-05-12 |
Glaxosmithkline Biolog Sa |
Influenza vakzinzusammensetzungen zur intradermaler verabreichung
|
WO2002067983A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Glaxosmithkline Biologicals S.A. |
Novel vaccine
|
EP1383456B1
(en)
|
2001-03-27 |
2007-02-21 |
Eli Lilly and Company |
Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JP4751009B2
(ja)
*
|
2001-04-13 |
2011-08-17 |
ベクトン・ディキンソン・アンド・カンパニー |
隠された針と受動シールドとを有する事前充填可能な皮内送出装置
|
WO2002083232A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Becton, Dickinson And Company |
Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
|
WO2002087494A2
(en)
*
|
2001-04-27 |
2002-11-07 |
Glaxosmithkline Biologicals, Sa |
Novel vaccine
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
BR0210628A
(pt)
*
|
2001-06-29 |
2004-08-10 |
Becton Dickinson Co |
Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US20030073609A1
(en)
*
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
US6918918B1
(en)
|
2001-08-14 |
2005-07-19 |
Steven Schraga |
Single use lancet assembly
|
US8048097B2
(en)
*
|
2001-08-14 |
2011-11-01 |
Steven Schraga |
Single use lancet assembly
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
ES2257597T3
(es)
*
|
2001-11-30 |
2006-08-01 |
Novo Nordisk A/S |
Ensamblaje de aguja de seguridad.
|
US20050033230A1
(en)
*
|
2002-02-15 |
2005-02-10 |
Alchas Paul G. |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
DE10207276A1
(de)
*
|
2002-02-21 |
2003-09-11 |
Disetronic Licensing Ag |
Nadel-Insertionsvorrichtung mit quer bewegbarem Halteelement
|
CH695758A5
(de)
*
|
2002-03-05 |
2006-08-31 |
Tecpharma Licensing Ag |
Kühlvorrichtung für Injektionsgeräte.
|
US8715309B2
(en)
|
2002-04-29 |
2014-05-06 |
Steven Schraga |
Lancet device
|
US20040039407A1
(en)
|
2002-04-29 |
2004-02-26 |
Steven Schraga |
Lancet device
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
CN1655834A
(zh)
*
|
2002-05-06 |
2005-08-17 |
贝克顿·迪金森公司 |
用于控制药代动力学的方法和装置
|
WO2004020014A2
(en)
*
|
2002-08-30 |
2004-03-11 |
Becton, Dickinson And Company |
Method of controlling pharmacokinetics of immunomodulatory compounds
|
MXPA05007963A
(es)
|
2003-01-30 |
2005-09-20 |
Becton Dickinson Co |
Dispositivo para suministro intradermico, con geometria superficial que se acopla al contorno de la piel.
|
WO2005026375A2
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
US20050163711A1
(en)
*
|
2003-06-13 |
2005-07-28 |
Becton, Dickinson And Company, Inc. |
Intra-dermal delivery of biologically active agents
|
US8932264B2
(en)
*
|
2003-08-11 |
2015-01-13 |
Becton, Dickinson And Company |
Medication delivery pen assembly with needle locking safety shield
|
JP3100042U
(ja)
*
|
2003-08-26 |
2004-04-30 |
アルプス電気株式会社 |
テレビジョンチューナ
|
CA2536669A1
(en)
*
|
2003-08-26 |
2005-03-17 |
Becton, Dickinson And Company |
Methods for intradermal delivery of therapeutics agents
|
EP3354308B1
(en)
|
2003-08-28 |
2020-11-11 |
Becton, Dickinson and Company |
Intradermal injection device
|
WO2005034949A1
(en)
*
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
FR2861284B1
(fr)
*
|
2003-10-24 |
2005-12-30 |
Gaetan Terrasse |
Dispositif d'inoculation therapeutique et diagnostique
|
WO2005091922A2
(en)
*
|
2004-03-03 |
2005-10-06 |
Becton, Dickinson And Company |
Methods and devices for improving delivery of a substance to skin
|
US20050256182A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Sutter Diane E |
Formulations of anti-pain agents and methods of using the same
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060178686A1
(en)
*
|
2005-02-07 |
2006-08-10 |
Steven Schraga |
Single use lancet device
|
US20090081253A1
(en)
|
2005-03-23 |
2009-03-26 |
Glaxosmithkline Biologicals S.A. |
Composition
|
TR201910900T4
(tr)
|
2005-04-04 |
2019-08-21 |
Univ Florida |
Desferritiyokin polieter analogları.
|
KR101446025B1
(ko)
*
|
2005-08-03 |
2014-10-01 |
아이바이오, 인크. |
면역글로불린의 생산을 위한 조성물 및 방법
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
CA2642056A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
WO2008048344A2
(en)
*
|
2006-02-13 |
2008-04-24 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
JP2009526526A
(ja)
*
|
2006-02-13 |
2009-07-23 |
フラウンホーファー ユーエスエー, インコーポレイテッド |
インフルエンザ抗原、ワクチン組成物、および関連する方法
|
CA2644694C
(en)
*
|
2006-03-10 |
2014-05-13 |
Sangeeta N. Bhatia |
Triggered self-assembly conjugates and nanosystems
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
US20090325944A1
(en)
*
|
2006-04-12 |
2009-12-31 |
Suzanne Walker Kahne |
Methods and Compositions for Modulating Glycosylation
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
CA2656298A1
(en)
|
2006-06-02 |
2007-12-13 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
ES2525572T3
(es)
|
2006-07-17 |
2014-12-26 |
Glaxosmithkline Biologicals S.A. |
Vacuna antigripal
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
WO2008021415A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Massachusetts Institute Of Technology |
Glycan data mining system
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
JO3598B1
(ar)
*
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
US7811254B2
(en)
*
|
2006-10-18 |
2010-10-12 |
Meridian Medical Technologies, Inc. |
Autoinjector with needle depth adapter
|
SG177184A1
(en)
|
2006-12-01 |
2012-01-30 |
Anterios Inc |
Amphiphilic entity nanoparticles
|
US20080213377A1
(en)
*
|
2006-12-08 |
2008-09-04 |
Bhatia Sangeeta N |
Delivery of Nanoparticles and/or Agents to Cells
|
EP2474526A3
(en)
|
2006-12-26 |
2012-07-25 |
Lantheus Medical Imaging, Inc. |
Ligands for imaging cardiac innervation
|
JP5649825B2
(ja)
|
2007-01-31 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
安定化させたp53ペプチドおよびその使用法
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
NZ579994A
(en)
|
2007-03-15 |
2011-09-30 |
Univ Florida |
Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
KR20160061439A
(ko)
|
2007-03-28 |
2016-05-31 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스티칭된 폴리펩티드
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
US8778348B2
(en)
*
|
2007-04-28 |
2014-07-15 |
Ibio Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
AU2008263970B2
(en)
*
|
2007-06-14 |
2014-01-30 |
Crucell Switzerland Ag |
Intradermal influenza vaccine
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
US8404252B2
(en)
*
|
2007-07-11 |
2013-03-26 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
CA2696764A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
|
EP2205074A4
(en)
*
|
2007-10-04 |
2013-07-31 |
Harvard College |
ANALOGUES OF THE MOENOMYCIN, METHODS OF SYNTHESIS AND USES THEREOF
|
MX350501B
(es)
|
2007-10-12 |
2017-09-07 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
WO2009089119A2
(en)
*
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
WO2009114777A1
(en)
|
2008-03-13 |
2009-09-17 |
Becton, Dickinson And Company |
Safety needle assembly
|
EP2262558B1
(en)
|
2008-03-13 |
2016-11-16 |
Becton, Dickinson and Company |
Safety pen needle assembly having shielding for patient and non-patient ends
|
US8801673B2
(en)
|
2008-03-13 |
2014-08-12 |
Becton Dickinson & Company |
Safety pen needle assembly having shield for non-patient end
|
CN102046179B
(zh)
*
|
2008-04-09 |
2015-01-14 |
英菲尼提制药公司 |
脂肪酸酰胺水解酶抑制剂
|
US20110112040A1
(en)
*
|
2008-04-28 |
2011-05-12 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
KR102080429B1
(ko)
|
2008-06-26 |
2020-02-21 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGATURE OF STAPLED POLYPEPTIDES
|
AU2009274571A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Massachusetts Institute Of Technology |
Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8591905B2
(en)
*
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
WO2010077806A1
(en)
|
2008-12-15 |
2010-07-08 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
US20110008867A1
(en)
*
|
2008-12-22 |
2011-01-13 |
Greenlight Biosciences |
Compositions and methods for the production of a compound
|
CA2757679A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
US8541581B2
(en)
|
2009-04-07 |
2013-09-24 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
EP2438046A4
(en)
|
2009-06-01 |
2013-04-17 |
Harvard College |
O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF
|
CA2768299C
(en)
|
2009-07-13 |
2018-03-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
EP2528615B1
(en)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
EP2531511A1
(en)
*
|
2010-02-03 |
2012-12-12 |
Infinity Pharmaceuticals, Inc. |
Fatty acid amide hydrolase inhibitors
|
CA2789484C
(en)
|
2010-03-08 |
2019-10-22 |
Sloan-Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011140296A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Triazoles as inhibitors of fatty acid synthase
|
EP3159331A1
(en)
|
2010-05-05 |
2017-04-26 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
DK2566953T3
(en)
|
2010-05-07 |
2019-04-15 |
Greenlight Biosciences Inc |
METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
|
BR112012028806B1
(pt)
|
2010-05-11 |
2021-01-19 |
Lantheus Medical Imaging, Inc. |
Sal ascorbato de um composto para imagiologia, seu uso para a imagiologia médica ecomposição que o compreende
|
US9193989B2
(en)
|
2010-06-18 |
2015-11-24 |
Taiho Pharmaceutical Co., Ltd. |
PRPK-TPRKB modulators and uses thereof
|
EP2399631A1
(en)
*
|
2010-06-28 |
2011-12-28 |
Sanofi-Aventis Deutschland GmbH |
Auto-injector with injection damper
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
KR102104762B1
(ko)
|
2010-08-13 |
2020-04-24 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
DK3219796T3
(da)
|
2010-08-31 |
2020-12-21 |
Greenlight Biosciences Inc |
Fremgangsmåder til kontrol af strømningen i metaboliske reaktionsveje ved hjælp af proteasemanipulation
|
AU2011305371B2
(en)
|
2010-09-21 |
2015-05-21 |
Massachusetts Institute Of Technology |
Human-adapted HA polypeptides, vaccines, and influenza treatment
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
CA2821992A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US10226527B2
(en)
|
2010-10-04 |
2019-03-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
JP6039569B2
(ja)
*
|
2010-11-09 |
2016-12-07 |
ノヴォ ノルディスク アー/エス |
二重アシル化されたglp−1誘導体
|
AU2011326427B2
(en)
|
2010-11-10 |
2016-01-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
BR112013017670B1
(pt)
|
2011-01-10 |
2022-07-19 |
Infinity Pharmaceuticals, Inc |
Processos de preparação de isoquinolinonas e formas sólidas de isoquinolinonas
|
EP2982373B1
(en)
|
2011-01-19 |
2018-06-13 |
Topokine Therapeutics, Inc. |
Methods and compostions for reducing body fat
|
EP2667945A1
(en)
|
2011-01-24 |
2013-12-04 |
Anterios, Inc. |
Oil compositions
|
US20120328701A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
WO2012103035A1
(en)
|
2011-01-24 |
2012-08-02 |
Anterios, Inc. |
Nanoparticle compositions
|
EP2680837A4
(en)
|
2011-03-03 |
2015-06-03 |
Tersus Pharmaceuticals Llc |
COMPOSITIONS AND METHODS COMPRISING C16: 1N7-PALMITOLATE
|
WO2012135615A2
(en)
|
2011-03-30 |
2012-10-04 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
CN103764166B
(zh)
|
2011-06-22 |
2017-10-24 |
通用医疗公司 |
蛋白质病的治疗
|
AR088218A1
(es)
|
2011-07-19 |
2014-05-21 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos utiles como inhibidores de pi3k
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
WO2013016193A2
(en)
|
2011-07-22 |
2013-01-31 |
Massachusetts Istitute Of Technology |
Activators of class i histone deacetlyases (hdacs) and uses thereof
|
CA2846431A1
(en)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
SG2014014377A
(en)
|
2011-09-09 |
2014-05-29 |
Greenlight Biosciences Inc |
Cell-free preparation of carbapenems
|
TWI700268B
(zh)
|
2011-09-09 |
2020-08-01 |
美商藍瑟斯醫學影像公司 |
用於合成及使用造影劑之組合物、方法及系統
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
ES2911677T3
(es)
|
2011-10-03 |
2022-05-20 |
Modernatx Inc |
Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos
|
KR20140100937A
(ko)
|
2011-10-18 |
2014-08-18 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
C−jun−n−末端キナーゼ(jnk)の阻害剤
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
DE12858350T1
(de)
|
2011-12-16 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte mrna zusammensetzungen
|
MX368275B
(es)
|
2011-12-16 |
2019-09-26 |
Univ Florida |
Usos de análogos de 4'-desferritiocina.
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
CN104144695A
(zh)
|
2012-02-15 |
2014-11-12 |
爱勒让治疗公司 |
三唑交联的和硫醚交联的拟肽大环化合物
|
CN107216380A
(zh)
|
2012-02-15 |
2017-09-29 |
爱勒让治疗公司 |
拟肽大环化合物
|
US9902985B2
(en)
|
2012-04-06 |
2018-02-27 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
EP2834254A2
(en)
|
2012-04-06 |
2015-02-11 |
President and Fellows of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
JP6431477B2
(ja)
|
2012-05-10 |
2018-12-05 |
マサチューセッツ インスティテュート オブ テクノロジー |
インフルエンザの中和のための薬剤
|
WO2014024026A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
DK2920197T3
(da)
|
2012-09-26 |
2021-05-31 |
Harvard College |
Prolinlåste sammenhæftede peptider og anvendelser deraf
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
RS58700B1
(sr)
|
2012-10-12 |
2019-06-28 |
Broad Inst Inc |
Gsk3 inhibitori i postupci njihove primene
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
TR201812261T4
(tr)
|
2012-11-01 |
2018-11-21 |
Infinity Pharmaceuticals Inc |
Pi3 ki̇naz i̇zoform modülatörleri̇ i̇le kanser tedavi̇si̇
|
KR20150082307A
(ko)
|
2012-11-01 |
2015-07-15 |
에일러론 테라퓨틱스 인코포레이티드 |
이치환 아미노산 및 이의 제조 및 사용 방법
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
JP5877620B2
(ja)
|
2012-11-21 |
2016-03-08 |
トポカイン セラピューティックス, インコーポレイテッド |
体脂肪を局所的に増大させるための方法および組成物
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
US9604930B2
(en)
|
2012-12-21 |
2017-03-28 |
Epizyme, Inc. |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
|
EP2935240A1
(en)
|
2012-12-21 |
2015-10-28 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
WO2014100716A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
EP2946014A2
(en)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
AU2014214844B2
(en)
|
2013-02-07 |
2017-12-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
KR102637496B1
(ko)
|
2013-03-13 |
2024-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스테이플드 및 스티치드 폴리펩티드 및 그의 용도
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
AU2014248090B2
(en)
|
2013-04-03 |
2018-08-02 |
N-Fold Llc |
Novel nanoparticle compositions
|
MX2015014026A
(es)
|
2013-04-04 |
2016-08-03 |
Harvard College |
Macrolidos y metodos para su preparacion y uso.
|
WO2014169073A1
(en)
|
2013-04-09 |
2014-10-16 |
Massachusetts Institute Of Technology |
Drug delivery polymer and uses thereof
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(ru)
|
2013-05-10 |
2018-06-16 |
|
|
SG11201509842SA
(en)
|
2013-05-30 |
2015-12-30 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
WO2014201127A2
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
MX2015017274A
(es)
|
2013-06-14 |
2016-08-04 |
Harvard College |
Moduladores del receptor del polipéptido insulina estabilizados.
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
KR20160037194A
(ko)
|
2013-08-05 |
2016-04-05 |
그린라이트 바이오사이언시스, 아이엔씨. |
프로테아제 분열 위치를 갖는 엔지니어링된 프로테인
|
BE1022008B1
(fr)
|
2013-08-05 |
2016-02-03 |
Glaxosmithkline Biologicals S.A. |
Compositions immunogenes combinees
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
WO2015048121A1
(en)
|
2013-09-25 |
2015-04-02 |
University Of Florida Research Foundation, Inc. |
Vitamin c prodrugs and uses thereof
|
MY175778A
(en)
|
2013-10-04 |
2020-07-08 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
KR20160099084A
(ko)
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|
CA2873770A1
(en)
|
2013-12-10 |
2015-06-10 |
Becton, Dickinson And Company |
Active safety pen needle assembly
|
ES2598061T3
(es)
|
2013-12-10 |
2017-01-25 |
Becton, Dickinson And Company |
Conjunto pasivo de seguridad de la aguja de jeringa tipo pluma
|
PE20161405A1
(es)
|
2013-12-24 |
2017-01-18 |
Harvard College |
Analogos de cortistatina y sintesis y usos de los mismos
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015109180A2
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3099693A4
(en)
|
2014-01-31 |
2017-08-16 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
MX2016011517A
(es)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
|
CN106456628A
(zh)
|
2014-03-19 |
2017-02-22 |
无限药品股份有限公司 |
用于治疗PI3K‑γ介导的障碍的杂环化合物
|
TWI687428B
(zh)
|
2014-03-27 |
2020-03-11 |
中央研究院 |
反應性標記化合物及其用途
|
WO2015149016A2
(en)
|
2014-03-28 |
2015-10-01 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
WO2015164604A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
US10017477B2
(en)
|
2014-04-23 |
2018-07-10 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
EP3145523A4
(en)
|
2014-05-21 |
2018-02-21 |
President and Fellows of Harvard College |
Ras inhibitory peptides and uses thereof
|
JP7062361B2
(ja)
|
2014-05-27 |
2022-05-06 |
アカデミア シニカ |
抗her2糖操作抗体群およびその使用
|
JP7093612B2
(ja)
|
2014-05-27 |
2022-06-30 |
アカデミア シニカ |
Bacteroides由来のフコシダーゼおよびそれを使用する方法
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
CN106573971A
(zh)
|
2014-05-27 |
2017-04-19 |
中央研究院 |
抗cd20醣抗体及其用途
|
JP7063538B2
(ja)
|
2014-05-28 |
2022-05-09 |
アカデミア シニカ |
抗TNFα糖操作抗体群およびその使用
|
MX2016016533A
(es)
|
2014-06-13 |
2017-05-01 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunogenas.
|
AU2015277786B2
(en)
|
2014-06-19 |
2019-04-18 |
Takeda Pharmaceutical Company Limited |
Heteroaryl compounds for kinase inhibition
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
EP3164379A1
(en)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
EP3169699A4
(en)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Cancer vaccine compositions and methods of use thereof
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
AU2015315294B2
(en)
|
2014-09-08 |
2020-09-17 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
BR112017005598A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
SG10201902598VA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2965169C
(en)
|
2014-10-21 |
2021-11-16 |
Ariad Pharmaceuticals, Inc. |
Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine
|
WO2016066618A2
(en)
|
2014-10-28 |
2016-05-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
US10174022B2
(en)
|
2014-12-10 |
2019-01-08 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
|
AU2015364280A1
(en)
|
2014-12-18 |
2017-07-06 |
Windgap Medical, Inc. |
Method and compositions for dissolving or solubilizing therapeutic agents
|
AU2015371251B2
(en)
|
2014-12-23 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
EP3237066B1
(en)
|
2014-12-23 |
2020-10-21 |
Sloan-Kettering Institute for Cancer Research |
Polymorph of granaticin b
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
TWI736523B
(zh)
|
2015-01-24 |
2021-08-21 |
中央研究院 |
新穎聚醣結合物及其使用方法
|
EP3294318A4
(en)
|
2015-03-20 |
2019-04-03 |
Aileron Therapeutics, Inc. |
PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
|
US10550121B2
(en)
|
2015-03-27 |
2020-02-04 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
SG11201707370WA
(en)
|
2015-03-30 |
2017-10-30 |
Greenlight Biosciences Inc |
Cell-free production of ribonucleic acid
|
KR20170140306A
(ko)
|
2015-04-27 |
2017-12-20 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
EP3310764B1
(en)
|
2015-06-19 |
2023-04-19 |
Massachusetts Institute of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2996978A1
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
PL3350157T3
(pl)
|
2015-09-17 |
2022-05-16 |
Modernatx, Inc. |
Związki i kompozycje do dostarczania wewnątrzkomórkowego środków terapeutycznych
|
EP4101930A1
(en)
|
2015-09-17 |
2022-12-14 |
ModernaTX, Inc. |
Polynucleotides containing a stabilizing tail region
|
US9925170B2
(en)
|
2015-10-01 |
2018-03-27 |
Kythera Biopharmaceuticals, Inc. |
Methods of adipolysis and compositions useful therein
|
WO2017073658A1
(ja)
*
|
2015-10-30 |
2017-05-04 |
テルモ株式会社 |
グリップ及び注射器組立体
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
USD806246S1
(en)
|
2016-02-25 |
2017-12-26 |
Steven Schraga |
Lancet cover
|
JP2019515876A
(ja)
|
2016-03-08 |
2019-06-13 |
アカデミア シニカAcademia Sinica |
N−グリカンおよびそのアレイのモジュール合成のための方法
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
JP7011599B2
(ja)
|
2016-04-06 |
2022-02-10 |
グリーンライト バイオサイエンシーズ インコーポレーテッド |
リボ核酸の無細胞的生産
|
IL312520A
(en)
|
2016-06-03 |
2024-07-01 |
Sanofi Pasteur Inc |
Modification of transgenic influenza hemagglutinin polypeptides
|
US10105449B2
(en)
|
2016-06-07 |
2018-10-23 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP2019525901A
(ja)
|
2016-06-14 |
2019-09-12 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
脂質ナノ粒子の安定化製剤
|
EP3493837B1
(en)
|
2016-08-05 |
2022-08-31 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CN109890415B
(zh)
|
2016-08-05 |
2023-04-04 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
US10538592B2
(en)
|
2016-08-22 |
2020-01-21 |
Cho Pharma, Inc. |
Antibodies, binding fragments, and methods of use
|
US20180085555A1
(en)
*
|
2016-09-26 |
2018-03-29 |
Boston Scientific Scimed, Inc. |
Injection catheter
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
AU2017360346B2
(en)
|
2016-11-21 |
2023-11-23 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
FI3596041T3
(fi)
|
2017-03-15 |
2023-01-31 |
|
Yhdiste ja koostumuksia terapeuttisten aineiden antamiseen solun sisään
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
WO2018187630A1
(en)
|
2017-04-05 |
2018-10-11 |
The Broad Institute, Inc. |
Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
CN111465701A
(zh)
|
2017-10-11 |
2020-07-28 |
绿光生物科技股份有限公司 |
用于三磷酸核苷和核糖核酸生成的方法和组合物
|
EP3717033A4
(en)
|
2017-12-01 |
2021-08-25 |
North Carolina State University |
FIBRIN PARTICLES AND THEIR PRODUCTION METHODS
|
CN113056269A
(zh)
|
2018-09-13 |
2021-06-29 |
艾里奥治疗公司 |
纤溶酶原激活物抑制剂1(pai-1)抑制剂的用途
|
US20220105068A1
(en)
|
2018-09-13 |
2022-04-07 |
Eirion Therapeutics, Inc. |
Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
|
JP7410135B2
(ja)
|
2018-09-19 |
2024-01-09 |
モデルナティエックス インコーポレイテッド |
治療薬の細胞内送達のための化合物及び組成物
|
EP3852728A1
(en)
|
2018-09-20 |
2021-07-28 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
EP3890704A1
(en)
|
2018-12-03 |
2021-10-13 |
Eirion Therapeutics, Inc. |
Improved delivery of large agents
|
EP3911643A1
(en)
|
2019-01-16 |
2021-11-24 |
Curza Global LLC |
Antimicrobial compounds and methods
|
AU2020209170A1
(en)
|
2019-01-16 |
2021-08-12 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
KR20210135494A
(ko)
|
2019-01-31 |
2021-11-15 |
모더나티엑스, 인크. |
지질 나노입자의 제조 방법
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CA3139983A1
(en)
|
2019-05-14 |
2020-11-19 |
Eirion Therapeutics, Inc. |
Delaying peak effect and/or extending duration of response
|
CN110236781B
(zh)
*
|
2019-06-13 |
2021-06-29 |
南京医科大学眼科医院 |
一次性无菌可调节用治疗针
|
AU2020319876A1
(en)
|
2019-07-31 |
2022-02-24 |
Modernatx, Inc. |
Compositions and methods for delivery of RNA interference agents to immune cells
|
WO2021021729A1
(en)
|
2019-07-31 |
2021-02-04 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
JP2023501575A
(ja)
|
2019-11-13 |
2023-01-18 |
カーザ グローバル, エルエルシー |
抗菌化合物及び方法
|
MX2022009410A
(es)
|
2020-01-31 |
2022-10-18 |
Modernatx Inc |
Metodos de preparacion de nanoparticulas lipidicas.
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
EP4238567A1
(en)
|
2020-10-30 |
2023-09-06 |
Keio University |
Novel treatment and prevention of sarcopenia-related diseases
|
CN116710116A
(zh)
|
2020-10-30 |
2023-09-05 |
Xeno-Interface株式会社 |
β折叠股桥肽
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
CA3233926A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
IL312502A
(en)
|
2021-11-05 |
2024-07-01 |
Sanofi Sa |
Hybrid multivalent influenza vaccines containing hemagglutinin and neuraminidase and methods of using them
|
CA3237134A1
(en)
|
2021-11-05 |
2023-05-11 |
Timothy ALEFANTIS |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
TW202333654A
(zh)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
用於製備脂質奈米顆粒之方法
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023172592A1
(en)
*
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|